Published on Web 08/06/2010
Catalytic Asymmetric Aza-Morita-Baylis-Hillman Reaction of
Methyl Acrylate: Role of a Bifunctional La(O-iPr)3/
Linked-BINOL Complex
Takafumi Yukawa,† Bianca Seelig,†,‡ Yingjie Xu,† Hiroyuki Morimoto,†
Shigeki Matsunaga,*,† Albrecht Berkessel,*,‡ and Masakatsu Shibasaki*,§
Graduate School of Pharmaceutical Sciences, The UniVersity of Tokyo, Hongo 7-3-1,
Bunkyo-ku, Tokyo 113-0033, Japan, Department of Chemistry, UniVersity of Cologne,
Greinstr. 4, 50939 Cologne, Germany, and Institute of Microbial Chemistry,
Tokyo, Kamiosaki 3-14-23, Shinagawa-ku, Tokyo 141-0021, Japan
Received April 19, 2010; E-mail: smatsuna@mol.f.u-tokyo.ac.jp; berkessel@uni-koeln.de;
Abstract: The catalytic asymmetric aza-Morita-Baylis-Hillman reaction using unactivated methyl acrylate
is described. A simple Lewis acidic metal catalyst, such as La(OTf)3, was not suitable for the reaction, but
rare earth metal alkoxide/linked-BINOL complexes possessing bifunctional Lewis acid and Brønsted base
properties efficiently promoted the reaction in combination with an achiral nucleophilic organocatalyst. The
combined use of a La(O-iPr)3/(S,S)-TMS-linked-BINOL complex with a catalytic amount of DABCO promoted
the aza-Morita-Baylis-Hillman reaction of a broad range of N-diphenylphosphinoyl imines. Products from
aryl, heteroaryl, and alkenyl imines were obtained in 67-99% yield and 81-95% ee. It is noteworthy that
isomerizable alkyl imines could be employed as well, giving products in 78-89% yield and 94-98% ee.
Initial rate kinetic studies as well as kinetic isotope effect experiments using R-deuterio-methyl acrylate
support the importance of both the nucleophilicity of La-enolate and the Brønsted basicity of a La-catalyst
for promoting the reaction.
lates as nucleophiles, however, are limited.6-8 Jacobsen6
reported a chiral thiourea combined with a stoichiometric
amount of DABCO for nonisomerizable aryl and heteroaryl
imines in combination with unactivated methyl acrylate. Excel-
lent enantioselectivity was achieved for the first time with
acrylates, but the product yields were not satisfactory. Recently,
Zhu and Masson7a achieved notable advances using bifunctional
ꢀ-isocupreidine derivatives as catalysts. High enantioselectivity
and high yield were realized for aryl and heteroaryl imines with
an activated naphthyl acrylate. In 2010, Zhu and Masson also
successfully realized good yield and excellent enantioselectivity
with isomerizable alkyl imines for the first time,7b but the use
of an activated acrylate was still essential. Compared with
activated acrylates, methyl acrylate is by far the cheapest and
readily available reagent. Consequently, the development of a
new strategy to overcome the poor reactivity of methyl acrylate
in the aza-MBH reaction is highly desirable. Herein, we describe
the successful application of a chiral Lewis acid/Brønsted base
bifunctional rare earth metal catalyst in combination with a
nucleophilic organocatalyst. The combination of bifunctional
La(O-iPr)3/(S,S)-linked-BINOL 1 (Figure 1) complexes9,10 with
DABCO provides good yields and enantioselectivities for aryl,
1. Introduction
The catalytic asymmetric aza-Morita-Baylis-Hillman (aza-
MBH) reaction, i.e. the nucleophile-catalyzed reaction of
electron-deficient alkenes with imines, provides direct access
to functionalized chiral ꢀ-amino carbonyl compounds.1,2 Shi,3
Sasai,4 and others5 have reported various bifunctional hydrogen
bond/nucleophile organocatalysts that realize highly enantiose-
lective aza-MBH reactions using enones as nucleophiles. Highly
enantioselective examples (>90% ee) using less reactive acry-
† Graduate School of Pharmaceutical Sciences, The University of Tokyo.
‡ Department of Chemistry, University of Cologne.
§ Institute of Microbial Chemistry, Tokyo.
(1) General review on aza-MBH reactions and their applications: Declerck,
V.; Martinez, J.; Lamaty, F. Chem. ReV. 2009, 109, 1.
(2) Reviews on catalytic enantioselective aza-MBH reactions: (a) Masson,
G.; Housseman, C.; Zhu, J. Angew. Chem., Int. Ed. 2007, 46, 4614.
(b) Shi, Y.-L.; Shi, M. Eur. J. Org. Chem. 2007, 2905.
(3) (a) Shi, M.; Xu, Y.-M. Angew. Chem., Int. Ed. 2002, 41, 4507. (b)
Shi, M.; Xu, Y.-M.; Shi, Y.-L. Chem.sEur. J. 2005, 11, 1794. (c)
Shi, M.; Chen, L.-H.; Li, C.-Q. J. Am. Chem. Soc. 2005, 127, 3790.
(d) Liu, Y.-H.; Chen, L.-H.; Shi, M. AdV. Synth. Catal. 2006, 348,
973. (e) Shi, Y.-L.; Shi, M. AdV. Synth. Catal. 2007, 349, 2129. (f)
Guan, X.-Y.; Jiang, Y.-Q.; Shi, M. Eur. J. Org. Chem. 2008, 2150.
(g) Qi, M.-J.; Ai, T.; Shi, M.; Li, G. Tetrahedron 2008, 64, 1181. See
also ref 2b.
(4) (a) Matsui, K.; Takizawa, S.; Sasai, H. J. Am. Chem. Soc. 2005, 127,
3680. (b) Matsui, K.; Takizawa, S.; Sasai, H. Synlett 2006, 761.
(5) For selected recent examples, see: (a) Abermil, N.; Masson, G.; Zhu,
J. Org. Lett. 2009, 11, 4648. (b) Garnier, J.-M.; Liu, F. Org. Biomol.
Chem. 2009, 7, 1272. (c) Gausepohl, R.; Buskens, P.; Kleinen, J.;
Bruckmann, A.; Lehmann, C. W.; Klankermayer, J.; Leitner, W.
Angew. Chem., Int. Ed. 2006, 45, 3689. For other examples, see refs
1 and 2.
(6) Raheem, I. T.; Jacobsen, E. N. AdV. Synth. Catal. 2005, 347, 1701.
(7) (a) Abermil, N.; Masson, G.; Zhu, J. J. Am. Chem. Soc. 2008, 130,
12596. (b) Abermil, N.; Masson, G.; Zhu, J. AdV. Synth. Catal. 2010,
352, 656.
(8) For partially successful early trials using acrylates, see ref 3a,c. See
also: (a) Balan, D.; Adolfsson, H. Tetrahedron Lett. 2003, 44, 2521.
(b) Kawahara, S.; Nakano, A.; Esumi, T.; Iwabuchi, Y.; Hatakeyama,
S. Org. Lett. 2003, 5, 3103.
9
11988 J. AM. CHEM. SOC. 2010, 132, 11988–11992
10.1021/ja103294a 2010 American Chemical Society